These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12973454)

  • 21. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
    Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
    J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Fucidic acid in staphylococcal infection.
    Goodwin AW; Rich GE; Tynan MJ
    Lancet; 1973 Dec; 2(7844):1504-5. PubMed ID: 4129354
    [No Abstract]   [Full Text] [Related]  

  • 23. Sodium fusidate.
    S Afr Med J; 1969 Dec; 43(51):1537. PubMed ID: 5372049
    [No Abstract]   [Full Text] [Related]  

  • 24. Sodium fusidate in steroid resistant relapses of multiple sclerosis.
    Nicoletti F; Patti F; Nicoletti A; L'Espiscopo MR; DiMarco R; Bendtzen K; Reggio A
    Mult Scler; 1999 Dec; 5(6):377. PubMed ID: 10644161
    [No Abstract]   [Full Text] [Related]  

  • 25. Chitosan-tailored lipidic nanoconstructs of Fusidic acid as promising vehicle for wound infections: An explorative study.
    Thakur K; Sharma G; Singh B; Chhibber S; Patil AB; Katare OP
    Int J Biol Macromol; 2018 Aug; 115():1012-1025. PubMed ID: 29680503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protostadienol biosynthesis and metabolism in the pathogenic fungus Aspergillus fumigatus.
    Lodeiro S; Xiong Q; Wilson WK; Ivanova Y; Smith ML; May GS; Matsuda SP
    Org Lett; 2009 Mar; 11(6):1241-4. PubMed ID: 19216560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fusidin and its properties].
    Vikhrova NM; Petrova MA; Fomina IP; Navashin SM
    Antibiotiki; 1967 Jun; 12(6):451-4. PubMed ID: 5187280
    [No Abstract]   [Full Text] [Related]  

  • 28. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
    Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
    Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic therapy of chronic post-traumatic osteomyelitis.
    Hierholzer G; Rehn J; Knothe H; Masterson J
    J Bone Joint Surg Br; 1974 Nov; 56-B(4):721-9. PubMed ID: 4452720
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotics for gram-positive organisms.
    Pagan FS
    Br J Hosp Med; 1981 Jan; 25(1):24-7. PubMed ID: 7470716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
    Downey DG; Kidd TJ; Coulter C; Bell SC
    J Cyst Fibros; 2005 Sep; 4(3):205-7. PubMed ID: 16019268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusidic acid in other infections.
    Golledge C
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S11-5. PubMed ID: 10528782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin.
    Yuen SL; McGarity B
    Med J Aust; 2003 Aug; 179(3):172. PubMed ID: 12885276
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases.
    Menday AP; Marsh BT
    Curr Med Res Opin; 1976; 4(2):132-8. PubMed ID: 1277881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Klebsiella oxytoca-associated colitis after oral administration of fusidic acid].
    Seksik P; Galula G; Maury E; Lévy VG; Offenstadt G
    Gastroenterol Clin Biol; 2000 May; 24(5):587-8. PubMed ID: 10891753
    [No Abstract]   [Full Text] [Related]  

  • 36. The prolonged use of intravenous fusidic acid in severe staphylococcal infection.
    Copperman IJ
    Br J Clin Pract; 1972 Feb; 26(2):83-4. PubMed ID: 5016911
    [No Abstract]   [Full Text] [Related]  

  • 37. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
    Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
    Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
    Aboltins CA; Page MA; Buising KL; Jenney AW; Daffy JR; Choong PF; Stanley PA
    Clin Microbiol Infect; 2007 Jun; 13(6):586-91. PubMed ID: 17331125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections.
    Hurdle JG; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2004 Aug; 54(2):549-52. PubMed ID: 15243028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.